 Baudax Bio Inc NASDAQ: BXRX has announced the online publication of Phase 3b study data highlighting the safety and efficacy of preoperative Anjeso meloxicam injection in patients undergoing unilateral total knee arthroplasty TKA when used within a multimodal analgesic regimen in the peer-reviewed medical journal Pain Medicine. Anjeso is indicated for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. 